Trials / Enrolling By Invitation
Enrolling By InvitationNCT07260578
Safety and Efficacy of Ellacor® Micro-coring® Following Best Practices on Technique and Post-Procedural Care
Safety and Efficacy of Ellacor Micro-coring Following Best Practices on Technique and Post-Procedural Care
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Cytrellis Biosystems, Inc. · Industry
- Sex
- All
- Age
- 45 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Since its inception of being marketed in the United States in 2021, physicians have used various post procedure skin care regimen to facilitate recovery. This study aims to examine the use of three post care products in five skin care regimens
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ellacor Micro-Coring Technology | ellacor will be used to treat moderate-severe wrinkles in the mid to lower face in subjects aged between 45-65. |
Timeline
- Start date
- 2025-11-26
- Primary completion
- 2026-05-01
- Completion
- 2026-06-01
- First posted
- 2025-12-03
- Last updated
- 2026-03-16
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07260578. Inclusion in this directory is not an endorsement.